SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday . The stock traded as high as $70.66 and last traded at $70.42, with a volume of 8538 shares trading hands. The stock had previously closed at $69.80.
SPDR S&P Pharmaceuticals ETF Trading Up 0.5%
The firm has a market capitalization of $504.86 million, a PE ratio of 14.28 and a beta of 0.58. The business has a fifty day moving average price of $64.28 and a two-hundred day moving average price of $59.18.
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of the stock. Turtle Creek Wealth Advisors LLC purchased a new position in SPDR S&P Pharmaceuticals ETF during the first quarter worth about $26,000. Western Wealth Management LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the 1st quarter worth approximately $34,000. Advisory Services Network LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth approximately $34,000. Fifth Third Bancorp acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the 1st quarter worth approximately $39,000. Finally, Kestra Advisory Services LLC purchased a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $151,000.
About SPDR S&P Pharmaceuticals ETF
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- 3 Stocks Taking Very Different Routes Through the Summer Rally
- Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
- CoreWeave Powers Up: The Asia Infrastructure Grab
- Boot Barn Stock Still Has Room to Run, But It Must Earn Its Premium
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
